BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 20629545)

  • 21. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
    Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
    J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
    Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
    J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of calcium sulfate in combination with demineralized freeze-dried bone allograft for the treatment of human intraosseous defects.
    Aichelmann-Reidy ME; Heath CD; Reynolds MA
    J Periodontol; 2004 Mar; 75(3):340-7. PubMed ID: 15088870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The soft tissue wall technique for the regenerative treatment of non-contained infrabony defects: a case series.
    Rasperini G; Acunzo R; Barnett A; Pagni G
    Int J Periodontics Restorative Dent; 2013; 33(3):e79-87. PubMed ID: 23593632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients.
    Trombelli L; Annunziata M; Belardo S; Farina R; Scabbia A; Guida L
    J Clin Periodontol; 2006 Jan; 33(1):69-75. PubMed ID: 16367859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials.
    Tu YK; Woolston A; Faggion CM
    J Clin Periodontol; 2010 Jan; 37(1):59-79. PubMed ID: 19958442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single minimally invasive surgical technique with an enamel matrix derivative to treat multiple adjacent intra-bony defects: clinical outcomes and patient morbidity.
    Cortellini P; Nieri M; Prato GP; Tonetti MS
    J Clin Periodontol; 2008 Jul; 35(7):605-13. PubMed ID: 18476997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
    J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans.
    Lovelace TB; Mellonig JT; Meffert RM; Jones AA; Nummikoski PV; Cochran DL
    J Periodontol; 1998 Sep; 69(9):1027-35. PubMed ID: 9776031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of intraosseous defects with bioabsorbable barriers alone or in combination with decalcified freeze-dried bone allograft: a randomized clinical trial.
    Trejo PM; Weltman R; Caffesse R
    J Periodontol; 2000 Dec; 71(12):1852-61. PubMed ID: 11156042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and late studies of EMD use in periodontal intrabony defects.
    Mueller VT; Welch K; Bratu DC; Wang HL
    J Periodontal Res; 2013 Feb; 48(1):117-25. PubMed ID: 22860751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
    Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
    J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane.
    Silvestri M; Sartori S; Rasperini G; Ricci G; Rota C; Cattaneo V
    J Clin Periodontol; 2003 May; 30(5):386-93. PubMed ID: 12716329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity.
    Cortellini P; Tonetti MS
    J Clin Periodontol; 2007 Jan; 34(1):87-93. PubMed ID: 17243998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.